February 26, 2025
GSK’s Nucala (mepolizumab) Accepted for Review by Health Canada for the Treatment of COPD
February 25, 2025
National Survey Reveals Low Understanding of Shingles Risk Factors and Lack of Concern Among Those at Increased Risk
February 13, 2025
Canada’s Drug Agency Recommends OJJAARA for Public Reimbursement
No current content.